The University of Chicago Header Logo

Connection

Thomas Gajewski to Farnesyltranstransferase

Back to Details
This is a "connection" page, showing publications Thomas Gajewski has written about Farnesyltranstransferase.
Thomas Gajewski
Connection Strength
0.657
Farnesyltranstransferase
  1. Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104). J Transl Med. 2012 Dec 10; 10:246.
    View in: PubMed
    Score: 0.391
  2. Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level. Blood. 2007 Sep 15; 110(6):1982-8.
    View in: PubMed
    Score: 0.267
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.